Wildtype Kras2 can inhibit lung carcinogenesis in mice
1Division of Human Cancer Genetics, The Ohio State University Comprehensive Cancer Center, 420 West 12th Avenue, Columbus, Ohio, USA.
Nature Genetics
|August 31, 2001
Summary
Wild-type Kras2 acts as a tumor suppressor in lung cancer, contrary to its proto-oncogene role. Its loss is frequent in lung tumors, increasing susceptibility to chemically induced lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ras genes are established proto-oncogenes, but their dominant role in cell transformation is debated.
- Loss of wild-type Kras2 alleles is frequently observed in lung adenocarcinomas.
Purpose of the Study:
- To investigate the potential tumor suppressor role of wild-type Kras2 in lung tumorigenesis.
- To analyze the impact of Kras2 deficiency on susceptibility to lung tumor induction.
Main Methods:
- Lung tumor bioassay in heterozygous Kras2-deficient mice and wild-type controls.
- Chemical induction of lung tumors.
- Detection of Kras2 mutations and analysis of wild-type Kras2 expression.
- Assessment of colony formation and tumor development in cell lines.
Main Results:
- Heterozygous Kras2-deficient mice showed increased susceptibility to chemically induced lung tumors.
- Activating Kras2 mutations were present in all induced lung tumors.
- Wild-type Kras2 inhibited colony formation and tumor development in cell lines.
- Allelic loss of wild-type Kras2 occurred in 67-100% of induced lung adenocarcinomas with mutant Kras2.
- An inverse correlation was observed between wild-type Kras2 expression and ERK activity.
Conclusions:
- Wild-type Kras2 exhibits tumor suppressor activity in lung tumorigenesis.
- Loss of wild-type Kras2 is a common event during lung tumor progression.
- These findings challenge the traditional view of ras genes solely as oncogenes.
Related Concept Videos
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity: